58 related articles for article (PubMed ID: 23988111)
1. Differential binding of latrunculins to G-actin: a molecular dynamics study.
Helal MA; Khalifa S; Ahmed S
J Chem Inf Model; 2013 Sep; 53(9):2369-75. PubMed ID: 23988111
[TBL] [Abstract][Full Text] [Related]
2. Semisynthetic latrunculin B analogs: studies of actin docking support a proposed mechanism for latrunculin bioactivity.
Kudrimoti S; Ahmed SA; Daga PR; Wahba AE; Khalifa SI; Doerksen RJ; Hamann MT
Bioorg Med Chem; 2009 Nov; 17(21):7517-22. PubMed ID: 19800245
[TBL] [Abstract][Full Text] [Related]
3. Latrunculin with a highly oxidized thiazolidinone ring: structure assignment and actin docking.
Ahmed SA; Odde S; Daga PR; Bowling JJ; Mesbah MK; Youssef DT; Khalifa SI; Doerksen RJ; Hamann MT
Org Lett; 2007 Nov; 9(23):4773-6. PubMed ID: 17929935
[TBL] [Abstract][Full Text] [Related]
4. A new dimension to the biosynthetic products isolated from the sponge Negombata magnifica.
Vilozny B; Amagata T; Mooberry SL; Crews P
J Nat Prod; 2004 Jun; 67(6):1055-7. PubMed ID: 15217296
[TBL] [Abstract][Full Text] [Related]
5. Bioactive natural and semisynthetic latrunculins.
El Sayed KA; Youssef DT; Marchetti D
J Nat Prod; 2006 Feb; 69(2):219-23. PubMed ID: 16499319
[TBL] [Abstract][Full Text] [Related]
6. Molecular Dynamics Simulation Reveal the Mechanism of Resistance of Mutant Actins to Latrunculin A - Insight into Specific Modifications to Design Novel Drugs to Overcome Resistance.
Lalitha R; R PK; Mohammed MM
Curr Comput Aided Drug Des; 2016; 12(2):107-18. PubMed ID: 27484118
[TBL] [Abstract][Full Text] [Related]
7. Latrunculins--novel marine macrolides that disrupt microfilament organization and affect cell growth: I. Comparison with cytochalasin D.
Spector I; Shochet NR; Blasberger D; Kashman Y
Cell Motil Cytoskeleton; 1989; 13(3):127-44. PubMed ID: 2776221
[TBL] [Abstract][Full Text] [Related]
8. Total syntheses of the actin-binding macrolides latrunculin A, B, C, M, S and 16-epi-latrunculin B.
Fürstner A; De Souza D; Turet L; Fenster MD; Parra-Rapado L; Wirtz C; Mynott R; Lehmann CW
Chemistry; 2007; 13(1):115-34. PubMed ID: 17091520
[TBL] [Abstract][Full Text] [Related]
9. Latrunculin analogues with improved biological profiles by "diverted total synthesis": preparation, evaluation, and computational analysis.
Fürstner A; Kirk D; Fenster MD; Aïssa C; De Souza D; Nevado C; Tuttle T; Thiel W; Müller O
Chemistry; 2007; 13(1):135-49. PubMed ID: 17091521
[TBL] [Abstract][Full Text] [Related]
10. Quantitative determination of latrunculins A and B in the Red Sea sponge Negombata magnifica by high performance liquid chromatography.
Khalifa S; Ahmed S; Mesbah M; Youssef D; Hamann M
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Feb; 832(1):47-51. PubMed ID: 16431167
[TBL] [Abstract][Full Text] [Related]
11. Actin-Dynamics in Plant Cells: The Function of Actin-Perturbing Substances: Jasplakinolide, Chondramides, Phalloidin, Cytochalasins, and Latrunculins.
Holzinger A; Blaas K
Methods Mol Biol; 2016; 1365():243-61. PubMed ID: 26498789
[TBL] [Abstract][Full Text] [Related]
12. Molecular and protein characterization of two species of the latrunculin-producing sponge Negombata from the Red Sea.
Eid ES; Abo-Elmatty DM; Hanora A; Mesbah NM; Abou-El-Ela SH
J Pharm Biomed Anal; 2011 Dec; 56(5):911-5. PubMed ID: 21852057
[TBL] [Abstract][Full Text] [Related]
13. 3D-QSAR studies of latrunculin-based actin polymerization inhibitors using CoMFA and CoMSIA approaches.
Khanfar MA; Youssef DT; El Sayed KA
Eur J Med Chem; 2010 Sep; 45(9):3662-8. PubMed ID: 20684858
[TBL] [Abstract][Full Text] [Related]
14. Semisynthetic latrunculin derivatives as inhibitors of metastatic breast cancer: biological evaluations, preliminary structure-activity relationship and molecular modeling studies.
Khanfar MA; Youssef DT; El Sayed KA
ChemMedChem; 2010 Feb; 5(2):274-85. PubMed ID: 20043312
[TBL] [Abstract][Full Text] [Related]
15. Diverted total synthesis: preparation of a focused library of latrunculin analogues and evaluation of their actin-binding properties.
Fürstner A; Kirk D; Fenster MD; Aïssa C; De Souza D; Müller O
Proc Natl Acad Sci U S A; 2005 Jun; 102(23):8103-8. PubMed ID: 15917332
[TBL] [Abstract][Full Text] [Related]
16. Latrunculin A and its C-17-O-carbamates inhibit prostate tumor cell invasion and HIF-1 activation in breast tumor cells.
Sayed KA; Khanfar MA; Shallal HM; Muralidharan A; Awate B; Youssef DT; Liu Y; Zhou YD; Nagle DG; Shah G
J Nat Prod; 2008 Mar; 71(3):396-402. PubMed ID: 18298079
[TBL] [Abstract][Full Text] [Related]
17. Influencing the Actin Dynamics in Plant Cells by Jasplakinolide, Chondramides, Phalloidin, Cytochalasins, and Latrunculins.
Holzinger A
Methods Mol Biol; 2022; 2364():177-198. PubMed ID: 34542854
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of interdomain motion in g-actin by the natural product latrunculin: a molecular dynamics study.
Rennebaum S; Caflisch A
Proteins; 2012 Aug; 80(8):1998-2008. PubMed ID: 22488806
[TBL] [Abstract][Full Text] [Related]
19. Toward computing relative configurations: 16-epi-latrunculin B, a new stereoisomer of the actin polymerization inhibitor latrunculin B.
Hoye TR; Ayyad SE; Eklov BM; Hashish NE; Shier WT; El-Sayed KA; Hamann MT
J Am Chem Soc; 2002 Jun; 124(25):7405-10. PubMed ID: 12071749
[TBL] [Abstract][Full Text] [Related]
20. Latrunculin resistance mechanism of non-conventional actin NAP1 uncovered by molecular dynamics simulations.
Morita R; Shigeta Y; Harada R
Cytoskeleton (Hoboken); 2024; 81(2-3):143-150. PubMed ID: 37815120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
